All companies
Visit website
SnapDNA
OperatingSnapDNA Corp
Biotech · Founded 2011
Solving the global food safety challenge
Valuation cap ⓘ
$40.0M
As of Sep 2023 · from SnapDNA Crowd SAFE 2 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$1,352,385
Across 2 rounds since 2020
Latest share price
$1.00
SnapDNA Crowd SAFE 2 offering price
Financials
FY2018–FY2023 · from SEC filings · hover any figure for its source$0
−$375K
2018
$0
−$696K
2019
$68K
−$337K
2020
$25K
−$738K
2021
$0
−$1.0M
2022
$0
−$707K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$67,937
$25,000
$0
$0
Cost of goods sold
$0
$0
$0
$0
$0
$0
Gross margin
—
—
100%
100%
—
—
Net income
-$374,512
-$695,911
-$337,160
-$738,328
-$1,023,712
-$707,276
Taxes paid
$0
$0
$1,890
$0
$0
$721
Balance sheet
Cash
$4,154
$124,466
$15,215
$592,511
$62,530
$165,997
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$57,944
$163,063
$22,680
$648,127
$334,688
$267,738
Short-term debt
$943,253
$1,309,233
$311,362
$359,752
$5,374,553
$609,227
Long-term debt
$2,387,600
$2,667,600
$4,172,850
$488,234
$1,743,147
$6,721,622
Total liabilities
$3,330,853
$3,976,833
$4,484,212
$847,986
$7,117,700
$7,330,848
Other
Headcount
—
3
—
4
4
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$28.0M
Valuation cap
$40.0M
Valuation cap
SnapDNA Crowd SAFE 1
SnapDNA Crowd SAFE 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $282.4K / $618KInvestors 408Valuation cap $40M
Raised $1.1M / $1.1MInvestors 1,850Valuation cap $28M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 3 of 6 annual reports (FY2020–FY2025)
1,850 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 14 filings on EDGARSource: ManualCIK 0001562529Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.